Dova Pharmaceuticals Inc logo

DOVA - Dova Pharmaceuticals Inc News Story

$28.04 0.0  0.0%

Last Trade - 11/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £10.0m
Position in Universe th / 6827

BRIEF-Dova Pharmaceuticals To Be Acquired By Swedish Orphan Biovitrum AB

Mon 30th September, 2019 7:06am
Sept 30 (Reuters) - Dova Pharmaceuticals Inc  DOVA.O :
    * DOVA PHARMACEUTICALS TO BE ACQUIRED BY SWEDISH ORPHAN
BIOVITRUM
AB (SOBI)
    * CONSIDERATION OF UP TO $29.00 PER SHARE INCLUDES $27.50
PER
SHARE IN UPFRONT CASH AND AN ADDITIONAL $1.50 PER SHARE
    * TOTAL POTENTIAL CONSIDERATION OF UP TO $915 MILLION ON A
FULLY
DILUTED BASIS
    * TRANSACTION EXPECTED TO BE COMPLETED IN Q4 2019
    * TRANSACTION WAS UNANIMOUSLY APPROVED BY BOARDS OF
DIRECTORS OF
BOTH COMPANIES

Source text for Eikon:  ID:nGNX4BRnM0 
Further company coverage:  DOVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.